N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant

por Sahasrabudhe, Siddhee A., Terluk, Marcia R., Kartha, Reena V.
Publicado 2023

Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies

por Sahasrabudhe, Siddhee A., Al-Kofahi, Mahmoud, Cloyd, James C., Weinreb, Neal, Kartha, Reena V.
Publicado 2021

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease

por Sahasrabudhe, Siddhee A., Terluk, Marcia R., Rudser, Kyle D., Cloyd, James C., Kartha, Reena V.
Publicado 2022

Physiologically‐Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug–Drug Interactions

por Sahasrabudhe, Siddhee A., Cheng, Shen, Al‐Kofahi, Mahmoud, Jarnes, Jeanine R., Weinreb, Neal J., Kartha, Reena V.
Publicado 2022

Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young Adults

por Sahasrabudhe, Siddhee A., Silamongkol, Thanharat, Park, Young Woo, Colette, Alanna, Eberly, Lynn E., Klimes-Dougan, Bonnie, Coles, Lisa D., Cloyd, James C., Öz, Gülin, Mueller, Bryon A., Kartha, Reena V., Cullen, Kathryn R.
Publicado 2021